Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Accounts Payables: 2014-2024

Historic Accounts Payables for KalVista Pharmaceuticals (KALV) over the last 8 years, with Apr 2024 value amounting to $9.1 million.

  • KalVista Pharmaceuticals' Accounts Payables was N/A to $5.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $5.7 million, marking a year-over-year change of. This contributed to the annual value of $9.1 million for FY2024, which is N/A change from last year.
  • Latest data reveals that KalVista Pharmaceuticals reported Accounts Payables of $9.1 million as of FY2024, which was up 443.05% from $1.7 million recorded in FY2020.
  • In the past 5 years, KalVista Pharmaceuticals' Accounts Payables ranged from a high of $9.1 million in FY2024 and a low of $1.7 million during FY2020.
  • In the last 1 years, KalVista Pharmaceuticals' Accounts Payables had a median value of $9.1 million in 2024 and averaged $9.1 million.
  • Data for KalVista Pharmaceuticals' Accounts Payables shows a maximum YoY plummeted of 41.36% (in 2020) over the last 5 years.
  • Yearly analysis of 2 years shows KalVista Pharmaceuticals' Accounts Payables stood at $1.7 million in 2020, then followed by $9.1 million in 2024.